12:00 AM
 | 
Nov 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

LuViva Advanced Cervical Scan regulatory update

Guided Therapeutics submitted an amendment to its PMA for LuViva Advanced Cervical Scan to detect cervical disease that leads to cancer. The amendment includes additional analysis requested by the agency. In May, the company...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >